Agoracom: Small Cap Investment - Zenith Epigenetics - Re: 6%

Zenithepigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free

Reply New Message

Back To Forum List View

6%

2

Dec 14, 2022 02:52PM

3

Dec 14, 2022 03:46PM

Dec 15, 2022 10:11AM

3

Dec 15, 2022 10:27AM

Dec 15, 2022 10:39AM

2

Dec 15, 2022 10:55AM

2

Dec 15, 2022 11:10AM

1

Dec 15, 2022 11:21AM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 6%

in response to

by

posted on Dec 15, 2022 11:28AM

Log in to use the IP Check tool ^[?]

+ if we were given some cash for zen-3694 + shown the exit door would we the sharholder still get a 6% royalty off of zen-3694 for years to come?

1 Recommendations

Loading...

Loading...

1

Dec 15, 2022 11:29AM

1

Dec 15, 2022 11:36AM

Reply New Message

Back To Forum List View

Share

Share

Share

Please to post a reply